Silica microspheres carry active pharmaceutical ingredients in a topical formulation to enable sustained release kinetics.
Hot melt extrusion forms an amorphous solid dispersion of resveratrol and curcumin, increasing solubility to overcome low oral bioavailability.
Fabricate uniform polyacrylamide-chitosan microparticles via UV-induced radical polymerization in a PDMS micromold.
Stealth targeted nanoparticles encapsulate poorly bioavailable drugs in a polymer matrix, resolving gastrointestinal degradation and low permeability.
Chiral stereochemistry in the hydrophobic block prevents accelerated blood clearance, enabling repeated administration to small cancers.
Humidified jet milling of glycopyrrolate prevents amorphous material generation, eliminating lengthy post-micronization conditioning steps.
An injectable composition of non-biodegradable polymeric particles provides stable tissue bulking through a lubricated surface and irregular shape.
S-type pyocins overcome antibiotic resistance by crossing outer membranes to destroy bacteria without triggering immune responses.
Tangential intake channel creates rotational airflow in a disaggregation chamber to improve dry powder medicament delivery accuracy.
Antibody-conjugated nanoparticles target hematopoietic stem cells, reducing cellular toxicity from electroporation.
Chroman derivatives combine bronchodilating and anti-inflammatory actions in a single compound for inhalation therapy.
A lanthanide metal phosphate microsphere replaces organic ligands with phosphate to increase metal content.
Transforming mRNA into an organic solvent-soluble form resolves stability and permeability bottlenecks by enabling single-phase mixing with ionizable lipids.
Hydrophilic polymers with covalently attached quadruple hydrogen bonding units enable reversible supramolecular cross-linking.
Inhaled ultrafine nanoparticles deliver contrast agents directly to lungs, reducing systemic toxicity while improving diagnostic precision.
Electrospun silica fiber dust acts as a collagen mimetic within topical carriers to support skin tissue regeneration.
Automated reactor controls pH and temperature to produce macroaggregated albumin particles with consistent size distribution.
Segmented release structure maintains morning therapeutic levels while preventing insomnia from nighttime dosing.
A core-double shell nanophosphor converts 800 nm infrared light into red emission via Yb-Ho energy transfer.
Co-dissolving APIs in a shared solvent ensures molecular homogeneity, resolving content uniformity issues in low-dose drug suspensions.
Azaindole derivatives inhibit Rho kinase enzymes, resolving insufficient therapeutic efficacy in existing treatments.
Basis particles coated with a water-insoluble film containing pH-modifying substances enable consistent drug elution.
Freeze-drying a rotavirus vaccine with specific stabilizers maintains potency at elevated temperatures, eliminating cold chain dependency.
Second harmonic generating nanoprobes eliminate dye saturation and autofluorescence interference to improve signal stability.
Nanoparticle-conjugated VIP attenuates graft-versus-host disease by shifting T cell polarization and reducing cytokine storm.
Freeze-dried glucagon in aprotic solvents maintains pH memory for emergency hypoglycemia treatment without refrigeration.
Encapsulating surfactant protein D in PLGA nanoparticles extends therapeutic duration and reduces administration frequency for respiratory distress syndrome.
Tolerizing immune modifying particles encapsulate gliadin epitopes to induce immune tolerance, replacing strict gluten-free diets.
Buckwheat and onion powders regenerate beta cells to restore insulin secretion, avoiding chemical side effects.
Administering Lactobacillus johnsonii modifies the gut microbiome to delay disease onset in ataxia telangiectasia patients by reducing oxidative stress.
Combines pH-dependent and independent polymers with organic acids to create a stable micro-environment for controlled drug release.
A segmented carrier system enables effective triple therapy delivery for elderly patients by ensuring uniform distribution and adequate particle size.
Solid water particles generate an electric field to attract and burst bacterial cell walls, overcoming drug resistance in superbugs.
A biocompatible adhesive adheres to biological tissues through hydrogen bonding and chelation mechanisms.
Capillary channels and osmotic pressure from composite disintegrants overcome stickiness of hygroscopic sartan drugs, enabling rapid disintegration.
Segmented branched PEG-lipids decrease immune system stimulation and prevent accelerated blood clearance during repeat dosing.
Chemical bonding of organic dyes to inorganic particles prevents dye decomposition under light irradiation, maintaining high photoacoustic signal intensity.
Camel single-domain antibodies bind human and mouse mesothelin, enabling CAR T cell evaluation in animal models.
Fatty acid modified levodopa derivatives sustain plasma levels and reduce peripheral degradation to treat Parkinson's disease.
A hydrophilic polymer and detergent stabilize proteins using a specific polyalcohol to sugar weight ratio.
A head-mounted wearable device with a projector and camera detects user movements and apparatus states to automate maintenance checklists.
Silica nanoparticles conjugated to phosphate binding peptides capture ions locally in the gastrointestinal tract.
Segmented nanoparticle carriers overcome membrane barriers to enable selective mitochondrial gene activation or repression.
A dry powder blend of pregelatinized modified starch and dehydro-xanthan gum reconstitutes into a smooth liquid.
Micronized 2,4,6-triiodophenol maintains stable plasma concentration during multiple doses, resolving pharmacokinetic challenges in treating pulmonary fibrosis.
Quinic acid-modified nanoparticles target E-selectin-positive cells via molecular recognition, increasing tumor accumulation beyond passive EPR effect limits.
Ultrasmall nanoparticles ingest to trigger ferroptosis, a distinct cell death mechanism driven by iron and reactive oxygen species.